News
UK first country to launch CSL's trivalent flu shot Aujemflu
CSL Seqirus' recently approved trivalent, cell-based influenza vaccine Aujemflu will be part of the UK's 2027/28 immunisation campaign.
News
Advocacy group pokes holes in Trump's MFN pricing claims
Public Citizen says claims for the drug price savings that are being delivered by Trump's Most-Favoured Nation deals with pharma are "a mirage."
Market Access
How new PBM transparency rules will alter drug pricing
The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.
News
AZ's gMG drug Klygefa nears EU approval
AstraZeneca's generalised myasthenia gravis (gMG) therapy Klygefa gets CHMP recommendation, alongside several other novel medicines.
Market Access
Sponsored
From first approval to lasting value: What sets successful e...
Approval may validate the science, but it does not secure commercial success. That outcome is determined by the decisions made before launch.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
